Short description
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
Description
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.
Last funding
Cannot Access
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2014
Exited on
August 28, 2017
Went public on
August 28, 2017
Stock symbol
SYBX
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$1230 - 4560
Sign in for full access
Investors
No Way, Noaccessforu, Blurry Noaccess, Noaccess, Noaccess, Nopepepe, Noaccessforu, Uh Ohhhh, Uh Ohhhh, Noaccess, Uh Ohhhh, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Alison Silva, Ankit Mahadevia, Dean Falb, Jim Collins, Timothy K. Lu